DK0451824T3 - Chelatdannende forbindelser og anvendelse deraf - Google Patents

Chelatdannende forbindelser og anvendelse deraf

Info

Publication number
DK0451824T3
DK0451824T3 DK91105704.0T DK91105704T DK0451824T3 DK 0451824 T3 DK0451824 T3 DK 0451824T3 DK 91105704 T DK91105704 T DK 91105704T DK 0451824 T3 DK0451824 T3 DK 0451824T3
Authority
DK
Denmark
Prior art keywords
ch2cooh
integer
hepatobiliary
chelate
chelating compound
Prior art date
Application number
DK91105704.0T
Other languages
English (en)
Inventor
Shigemi Seri
Hirohiko Yamauchi
Makoto Azuma
Yoji Arata
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14107923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0451824(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Application granted granted Critical
Publication of DK0451824T3 publication Critical patent/DK0451824T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
    • C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
    • C07C311/41—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A61K51/048—DTPA (diethylenetriamine tetraacetic acid)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/10—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Radiology & Medical Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK91105704.0T 1990-04-10 1991-04-10 Chelatdannende forbindelser og anvendelse deraf DK0451824T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2094353A JP2776953B2 (ja) 1990-04-10 1990-04-10 多官能性金属キレート化合物とその用途

Publications (1)

Publication Number Publication Date
DK0451824T3 true DK0451824T3 (da) 1996-03-11

Family

ID=14107923

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91105704.0T DK0451824T3 (da) 1990-04-10 1991-04-10 Chelatdannende forbindelser og anvendelse deraf

Country Status (10)

Country Link
US (2) US5196576A (da)
EP (1) EP0451824B1 (da)
JP (1) JP2776953B2 (da)
KR (1) KR100189388B1 (da)
AT (1) ATE134190T1 (da)
AU (1) AU634645B2 (da)
CA (1) CA2040204C (da)
DE (1) DE69117084T2 (da)
DK (1) DK0451824T3 (da)
ES (1) ES2085924T3 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2807852B2 (ja) * 1991-07-18 1998-10-08 株式会社ミドリ十字 新規キレート化剤、該キレート化剤と金属原子との錯化合物及びそれを含む診断剤
TW213864B (da) * 1991-08-01 1993-10-01 Squibb & Sons Inc
US5578287A (en) * 1992-06-09 1996-11-26 Neorx Corporation Three-step pretargeting methods using improved biotin-active agent
US6358490B2 (en) 1992-06-09 2002-03-19 Neorx Corporation Three-step pretargeting methods and compounds
US5911969A (en) 1992-06-09 1999-06-15 Neorx Corporation Pretargeting protocols for enhanced localization of active agents to target sites
US6022966A (en) * 1993-11-22 2000-02-08 Neorx Corporation Pretargeting methods and compounds
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
CA2134239C (en) * 1992-06-09 2004-11-23 Donald B. Axworthy Pretargeting methods and compounds
DK0603403T4 (da) * 1992-07-03 2002-12-16 Welfide Corp Nyt chelaterende middel, kompleksforbindelse mellem dette middel og et metalatom og diagnostisk middel indeholdende denne forbindelse
PT590766E (pt) * 1992-07-31 2000-07-31 Australian Nuclear Science Tec Complexos metalicos de hidroxiarilo contendo agentes quelantes de acido aminocarboxilico
US5807535A (en) * 1992-07-31 1998-09-15 Australian Nuclear Science & Technology Organisation Metal complexes of hydroxyaryl containing aminocarboxylic acid chelating agents
US6908903B1 (en) 1994-12-07 2005-06-21 Aletheon Pharmaceuticals, Inc. Cluster clearing agents
US6172045B1 (en) 1994-12-07 2001-01-09 Neorx Corporation Cluster clearing agents
US5955605A (en) * 1995-02-21 1999-09-21 Neorx Corporation Biotinidase resistant biotin-DOTA conjugates
EP1033471B1 (en) * 1999-03-02 2003-09-17 Rohm And Haas Company Improved recovery and transportation of heavy crude oils
DE10002939C1 (de) * 2000-01-13 2001-09-20 Schering Ag Paramagnetische DOTA-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung für die Herstellung von pharmazeutischen Mitteln
IL145210A (en) 2000-12-06 2011-12-29 Aposense Ltd Use of pmbc in the preparation of an agent for the selective binding of cells, a method for the detection of apoptosis and a pharmaceutical composition for the treatment of a disease characterized by the presence of apoptosis in cells, tissues or cellular structures
IL147812A0 (en) * 2001-03-16 2002-08-14 N S T Neurosurvival Technologi Method for targeting chemical compounds to cells and pharmaceutical compositions used therein
IL153183A (en) 2002-06-04 2010-05-17 Aposense Ltd Agents for imaging and diagnostic methods using them
EP1598082A4 (en) * 2003-02-27 2008-11-12 Univ Kyushu Nat Univ Corp CONTRASTANT FOR NUCLEAR PENTOMOGRAPHY
WO2006026038A1 (en) * 2004-08-26 2006-03-09 Mallinckrodt Inc. Luminescent metal complexes for monitoring renal function
CN101919090B (zh) 2007-11-12 2014-04-16 三洋电机株式会社 用于非水电解质二次电池的负极材料，用于非水电解质二次电池的负极，非水电解质二次电池，以及用作非水电解质二次电池负极材料的活性物质的多晶硅颗粒的制造方法
EP3089245B1 (en) 2013-12-25 2019-01-30 Shin-Etsu Chemical Co., Ltd. Negative electrode active material for nonaqueous electrolyte secondary batteries and method for producing same

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH607920A5 (da) * 1976-05-31 1978-12-15 Solco Basel Ag
US4352751A (en) * 1979-09-10 1982-10-05 Analytical Radiation Corporation Species-linked diamine triacetic acids and their chelates
US4418208A (en) * 1980-12-29 1983-11-29 E. R. Squibb & Sons, Inc. N-Substituted iminodiacetic acids
US4647447A (en) * 1981-07-24 1987-03-03 Schering Aktiengesellschaft Diagnostic media
US4957939A (en) * 1981-07-24 1990-09-18 Schering Aktiengesellschaft Sterile pharmaceutical compositions of gadolinium chelates useful enhancing NMR imaging
JPS5828718A (ja) * 1981-08-14 1983-02-19 Toyo Contact Lens Co Ltd ソフトコンタクトレンズ
US4454107A (en) * 1982-08-30 1984-06-12 Merck & Co., Inc. Tc99m-Phenida, radioscintigraphic agent for diagnosis of hepatoniliary disease
US4943523A (en) * 1984-01-30 1990-07-24 Enzo Biochem, Inc. Detectable molecules, method of preparation and use
IL83966A (en) * 1986-09-26 1992-03-29 Schering Ag Amides of aminopolycarboxylic acids and pharmaceutical compositions containing them
US4843062A (en) * 1987-12-23 1989-06-27 American Home Products Corporation N-acyl-N-napthoylglycines as aldose reductase inhibitors
JP2815615B2 (ja) * 1988-06-07 1998-10-27 日本メジフィジックス株式会社 ジエチレントリアミン五酢酸誘導体とその用途

Also Published As

Publication number Publication date
AU634645B2 (en) 1993-02-25
EP0451824A2 (en) 1991-10-16
EP0451824A3 (en) 1992-09-02
US5196576A (en) 1993-03-23
DE69117084T2 (de) 1996-10-02
AU7428191A (en) 1991-10-17
JP2776953B2 (ja) 1998-07-16
KR100189388B1 (ko) 1999-06-01
US5138039A (en) 1992-08-11
CA2040204A1 (en) 1991-10-11
KR910018346A (ko) 1991-11-30
JPH03291260A (ja) 1991-12-20
ATE134190T1 (de) 1996-02-15
CA2040204C (en) 2002-07-02
EP0451824B1 (en) 1996-02-14
DE69117084D1 (de) 1996-03-28
ES2085924T3 (es) 1996-06-16

Similar Documents

Publication Publication Date Title
EP0451824A3 (en) Chelating compounds and their use
NO900192D0 (no) Aminopolykarboksylsyrer og derivater derav.
FI935308A0 (fi) Joderade aroyloxiestrar
SE8301395D0 (sv) Kelatiserande foreningar med funktionella grupper vilka tillater kovalent koppling till bio-organiska molekyler
ATE39483T1 (de) Kondensierte pyrrolinon-derivate, und ihre herstellung.
KR970704864A (ko) 세정제 조성물
DK1063228T3 (da) Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf
MY115466A (en) Substituted cinnamic acid guanidides, a process for their preparation, their use as medicaments or diagnostic agents and medicaments comprising them.
DE69318711D1 (de) Desferrioxamine-b salze und ihre verwendung als oral wirksame eisen- chelatbildner
DK162045C (da) Trijodbenzenderivater, fremgangsmaade til fremstilling deraf og radiologiske praeparater indeholdende saadanne forbindelser
GB1229082A (da)
ATE117308T1 (de) N-substituierte aminoalkandiphosphonsäuren.
AU568064B2 (en) 4-acylamino-1-aza-adamantanes
SE7903687L (sv) Cyklohexylkarboxylsyraderivat och sett att framstella desamma
SE7702130L (sv) Forfarande for framstellning av n-(merkaptoacyl)-histidiner
DE69118520D1 (de) Sechsbindige liganden für radiographische abbildungsagenzien
DK82583D0 (da) Furyloxazolyleddikesyrederivater og fremgangsmader til fremstilling deraf
DK0517394T3 (da) Præparat mod ondartet svinelungesyge
NZ192844A (en) Thiazole derivatives and compositions
ATE101119T1 (de) Butensaeure-amide, deren salze, diese enthaltende pharmazeutische zusammensetzungen und verfahren zu deren herstellung.
ES467316A1 (es) Procedimiento para la obtencion de derivados de acidos metil-2 fenoxi-2 propionicos.
NO965302L (no) Alfa-cykloalkyl, aryl og aralkylsubstituerte polyjodinerte aroyloksyforbindelser
SE7614473L (sv) Nya aminer
IT1244649B (it) Procedimento per il trattamento di substrati com composti aromatici contenenti gruppi solfo, composizioni contenenti tali composti e loro preparazione